The Director, Field Reimbursement leads the national buy-and-bill FRM teams, supporting Oncology and Specialty, responsible for field-based access, reimbursement, and affordability support across HCP-administered, physician-dispensed brands.
This role is accountable for enterprise team performance, the quantification of FRM-driven business impact, and building an organization capable of scaling.
Set the vision, operating model, and execution priorities for both the Oncology and Specialty FRM teams, aligned to brand strategy and patient access goals.
Define and own KPIs (execution and performance specific to the brand/TA) for the FRM teams.
Lead, develop, and hold accountable the Associate Directors overseeing distinct TA-specific FRM teams.

Bachelor’s degree required.
8–12+ years of progressive experience in field leadership, reimbursement (buy and bill preferred), market access, and healthcare strategy
Minimum 5 years leading field-based teams, with demonstrated experience managing managers.
Proven track record of building or scaling an FRM or field organization – hiring, structuring, and developing teams through periods of rapid growth.
Experience across at least one of: Oncology, Ophthalmology/Eyecare, or complex HCP-administered specialty brands.
Deep working knowledge of Medicare Part B, J-codes, buy-and-bill reimbursement, prior authorization, and specialty distribution.
Experience defining or owning performance measurement frameworks that link FRM activity to business outcomes — not just reporting activity.

Director, Field Access and Reimbursement – Oncology & Specialty

Key skills